Showing results (11-20 of 56) with videos related to
Sort By:
Pageof 6
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|December 7, 2007
[Alerts system associated with computerized physician order entry: analysis and identification of improvement points]V Lerma Gaude, J L Poveda Andrés, I Font Noguera, et al.Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 9, 2010
[Cost minimisation analysis for darbepoetin alpha vs. epoetin alpha in chronic kidney disease patients on haemodialysis]C Cuesta Grueso, J L Poveda Andrés, J Garcia Pellicer, et al.Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 5, 2005
[Leflunomide: assessing teratogenic risk during the first trimester of pregnancy]C Casanova Sorní, E Romá Sánchez, A Pelufo Pellicer, et al.Journal of Clinical Pharmacy and Therapeutics|February 1, 1994
Selection of optimal prophylactic aminoglycoside dosage in cancer patients: population pharmacokinetic approachesJ P Ordovás, C L Ronchera, J L Poveda, et al.Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|April 23, 2004
[Cost-benefit analysis of a semi-automated process in the preparation of unit-doses by the Pharmacy Department]J L Poveda Andrés, M Hernández Sansalvador, A M Díez Martínez, et al.Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|February 15, 2007
[A descriptive study of erythropoietin use and cost in hematologic patients]A Pelufo Pellicer, E Monte Boquet, J L Poveda Andrés, et al.Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|April 23, 2008
[Medication errors in a tertiary hospital with three different drug delivery systems]C Climent, I Font-Noguera, J L Poveda Andrés, et al.Transplantation Proceedings|October 26, 2010
Clinical interest of pharmacogenetic polymorphisms in the immunosuppressive treatment after heart transplantationM J Herrero, L Almenar, C Jordán, et al.Expert Review of Pharmacoeconomics & Outcomes Research|June 22, 2019
Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in SpainJ L Poveda, J L Trillo, C Rubio-Terrés, et al.Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|February 4, 2014
[Boceprevir and telaprevir utilization: evaluation for the treatment of chronic hepatitis C]P Marrero-Álvarez, I Gil-Gómez, E Monte-Boquet, et al.Pageof 6